{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T15:57:46Z","timestamp":1776182266479,"version":"3.50.1"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2004,7,1]],"date-time":"2004-07-01T00:00:00Z","timestamp":1088640000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Urology"],"published-print":{"date-parts":[[2004,7]]},"DOI":"10.1097\/01.ju.0000132133.10470.bb","type":"journal-article","created":{"date-parts":[[2004,6,2]],"date-time":"2004-06-02T08:01:19Z","timestamp":1086163279000},"page":"90-93","source":"Crossref","is-referenced-by-count":64,"title":["RELATIONSHIP BETWEEN INITIAL PROSTATE SPECIFIC ANTIGEN LEVEL AND SUBSEQUENT PROSTATE CANCER DETECTION IN A LONGITUDINAL SCREENING STUDY"],"prefix":"10.1097","volume":"172","author":[{"given":"JO ANN V.","family":"ANTENOR","sequence":"first","affiliation":[{"name":"From the Departments of Neurology (JAVA), Psychiatry (KAR) and Surgery\/Urology (WJC), Washington University, School of Medicine, St. Louis, Missouri, and Department of Urology, Northwestern University (MH, RBN, WJC), Feinberg School of Medicine, Chicago, Illinois"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MISOP","family":"HAN","sequence":"additional","affiliation":[{"name":"From the Departments of Neurology (JAVA), Psychiatry (KAR) and Surgery\/Urology (WJC), Washington University, School of Medicine, St. Louis, Missouri, and Department of Urology, Northwestern University (MH, RBN, WJC), Feinberg School of Medicine, Chicago, Illinois"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KIMBERLY A.","family":"ROEHL","sequence":"additional","affiliation":[{"name":"From the Departments of Neurology (JAVA), Psychiatry (KAR) and Surgery\/Urology (WJC), Washington University, School of Medicine, St. Louis, Missouri, and Department of Urology, Northwestern University (MH, RBN, WJC), Feinberg School of Medicine, Chicago, Illinois"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ROBERT B.","family":"NADLER","sequence":"additional","affiliation":[{"name":"From the Departments of Neurology (JAVA), Psychiatry (KAR) and Surgery\/Urology (WJC), Washington University, School of Medicine, St. Louis, Missouri, and Department of Urology, Northwestern University (MH, RBN, WJC), Feinberg School of Medicine, Chicago, Illinois"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"WILLIAM J.","family":"CATALONA","sequence":"additional","affiliation":[{"name":"From the Departments of Neurology (JAVA), Psychiatry (KAR) and Surgery\/Urology (WJC), Washington University, School of Medicine, St. Louis, Missouri, and Department of Urology, Northwestern University (MH, RBN, WJC), Feinberg School of Medicine, Chicago, Illinois"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"10.1097\/01.ju.0000132133.10470.bb_bib1","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S0090-4295(01)01304-8","article-title":"Low levels of prostate-specific antigen predict long-term risk of prostate cancer: results from the Balti-more Longitudinal Study of Aging","volume":"58","author":"Fang","year":"2001","journal-title":"Urology"},{"key":"10.1097\/01.ju.0000132133.10470.bb_bib2","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1016\/S0022-5347(05)65532-2","article-title":"Validity of the prostate specific antigen test for prostate cancer screening: followup study with a bank of 21,000 sera in Finland","volume":"166","author":"Hakama","year":"2001","journal-title":"J Urol"},{"key":"10.1097\/01.ju.0000132133.10470.bb_bib3","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1001\/jama.273.4.289","article-title":"A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancer","volume":"273","author":"Gann","year":"1995","journal-title":"JAMA"},{"key":"10.1097\/01.ju.0000132133.10470.bb_bib4","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1001\/jama.277.18.1452","article-title":"Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng\/mL and benign prostate examination. Enhancement of specificity with free PSA measurements","volume":"277","author":"Catalona","year":"1997","journal-title":"JAMA"},{"key":"10.1097\/01.ju.0000132133.10470.bb_bib5","series-title":"American Joint Committee on Cancer Staging Manual","first-page":"181","article-title":"Prostate cancer staging","author":"Beahrs","year":"1992"},{"key":"10.1097\/01.ju.0000132133.10470.bb_bib6","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1056\/NEJM199104253241702","article-title":"Measurement of prostate-specific antigen in serum as a screening test for prostate cancer","volume":"324","author":"Catalona","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1097\/01.ju.0000132133.10470.bb_bib7","first-page":"267","article-title":"Prostate-specific antigen (PSA) best practice policy. American Urological Association (AUA)","volume":"14","year":"2000","journal-title":"Oncology"},{"key":"10.1097\/01.ju.0000132133.10470.bb_bib8","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3322\/canjclin.52.1.8","article-title":"American Cancer Society guidelines for the early detection of cancer","volume":"52","author":"Smith","year":"2002","journal-title":"CA Cancer J Clin"},{"key":"10.1097\/01.ju.0000132133.10470.bb_bib9","series-title":"Prostate Cancer Trends 1973\u20131995, SEER Program. 99-4543","author":"Stanford","year":"1999"},{"key":"10.1097\/01.ju.0000132133.10470.bb_bib10","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1093\/jnci\/94.13.981","article-title":"Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends","volume":"94","author":"Etzioni","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"10.1097\/01.ju.0000132133.10470.bb_bib11","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0090-4295(02)01875-7","article-title":"Prostate-specific antigen cutoff of 2.6 ng\/mL for prostate cancer screening is associated with favorable pathologic tumor features","volume":"60","author":"Krumholtz","year":"2002","journal-title":"Urology"},{"key":"10.1097\/01.ju.0000132133.10470.bb_bib12","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1159\/000020161","article-title":"Inflammation in prostate biopsies of men without prostatic malignancy or clinical prostatitis: correlation with total serum PSA and PSA density","volume":"37","author":"Schatteman","year":"2000","journal-title":"Eur Urol"},{"key":"10.1097\/01.ju.0000132133.10470.bb_bib13","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1016\/S0002-9440(10)65517-4","article-title":"Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis","volume":"155","author":"De Marzo","year":"1999","journal-title":"Am J Pathol"},{"key":"10.1097\/01.ju.0000132133.10470.bb_bib14","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/ng994","article-title":"Germline mutations and sequence variants of the macrophage scavenger receptor 1 gene are associated with prostate cancer risk","volume":"32","author":"Xu","year":"2002","journal-title":"Nat Genet"},{"key":"10.1097\/01.ju.0000132133.10470.bb_bib15","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/ng1021","article-title":"RNASEL Arg462Gln variant is implicated in up to 13% of prostate cancer cases","volume":"32","author":"Casey","year":"2002","journal-title":"Nat Genet"},{"key":"10.1097\/01.ju.0000132133.10470.bb_bib16","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1093\/jnci\/95.14.1044","article-title":"Association between genetic polymorphisms in the prostate-specific antigen gene promoter and serum prostate-specific antigen levels","volume":"95","author":"Cramer","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"10.1097\/01.ju.0000132133.10470.bb_bib17","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1054\/ghir.2000.0171","article-title":"Does the GH-IGF axis play a role in cancer pathogenesis?","volume":"10","author":"Cohen","year":"2000","journal-title":"Growth Horm IGF Res"},{"key":"10.1097\/01.ju.0000132133.10470.bb_bib18","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1002\/cncr.11208","article-title":"Progress in cancer screening practices in the United States: results from the 2000 National Health Interview Survey","volume":"97","author":"Swan","year":"2003","journal-title":"Cancer"},{"key":"10.1097\/01.ju.0000132133.10470.bb_bib19","doi-asserted-by":"crossref","first-page":"251S","DOI":"10.1016\/S0197-2456(00)00097-0","article-title":"Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Project Team: The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial of the National Cancer Institute: history, organization, and status","volume":"21","author":"Gohagan","year":"2000","journal-title":"Control Clin Trials"},{"key":"10.1097\/01.ju.0000132133.10470.bb_bib20","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/ijc.1588","article-title":"Large-scale randomized prostate cancer screening trials: program performances in the European Randomized Screening for Prostate Cancer trial and the Prostate, Lung, Colorectal and Ovary cancer trial","volume":"97","author":"de Koning","year":"2002","journal-title":"Int J Cancer"},{"key":"10.1097\/01.ju.0000132133.10470.bb_bib21","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1001\/jama.277.18.1456","article-title":"Recommended prostate-specific antigen testing intervals for the detection of curable prostate cancer","volume":"277","author":"Carter","year":"1997","journal-title":"JAMA"}],"container-title":["Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S0022534705618228?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S0022534705618228?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.jurology.com\/doi\/pdf\/10.1097\/01.ju.0000132133.10470.bb","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T06:11:14Z","timestamp":1651212674000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jurology.com\/doi\/10.1097\/01.ju.0000132133.10470.bb"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,7]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,7]]}},"alternative-id":["10.1097\/01.ju.0000132133.10470.bb"],"URL":"https:\/\/doi.org\/10.1097\/01.ju.0000132133.10470.bb","relation":{},"ISSN":["0022-5347","1527-3792"],"issn-type":[{"value":"0022-5347","type":"print"},{"value":"1527-3792","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,7]]}}}